Raymond James Financial Services Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Raymond James Financial Services Advisors's FLXN Position: Q4 2021 in Review

Raymond James Financial Services Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 604,271 shares — an estimated $3.69M sold.

Raymond James Financial Services Advisors first reported a position in FLXN in Q2 2016 and held it in 22 quarters. The position peaked at $4.38M in Q2 2020. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

• Raymond James Financial Services Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
• Raymond James Financial Services Advisors sold 604,271 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $3.69M.
• Raymond James Financial Services Advisors first reported a position in Flexion Therapeutics, Inc. in Q2 2016 and held it in 22 quarters.
• Raymond James Financial Services Advisors's Flexion Therapeutics, Inc. position peaked at $4.38M in Q2 2020.
• 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.